The Risk of Recurrent Venous Thromboembolism in Patients with and without Factor V Leiden
Sabine Eichinger(Medical University of Vienna), Paul A. Kyrle(Karl Landsteiner Society), Barbara Schneider(University of Vienna), Mirko Hirschl(Hanusch Hospital), Christine Mannhalter(Medical University of Vienna), Andreas Stümpfien(University of Vienna), Klaus Lechner, Ingrid Pabinger(Medical University of Vienna), Erich Minar, Christine Bialonczyk(Wilhelminen Hospital)
Cited by 206
Related Papers
Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination
|New England Journal of Medicine|2021|2.3k
von Willebrand Factor–Cleaving Protease in Thrombotic Thrombocytopenic Purpura and the Hemolytic–Uremic Syndrome
|New England Journal of Medicine|1998|1.7k
High Plasma Levels of Factor VIII and the Risk of Recurrent Venous Thromboembolism
|New England Journal of Medicine|2000|764
Increased fetal loss in women with heritable thrombophilia
|The Lancet|1996|677
Deep vein thrombosis
|The Lancet|2005|620